D. Allred

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

P. Fitzgibbons, P. Mangu, Robert B. Jenkins, 2014, Archives of pathology & laboratory medicine.

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

M. Dowsett, S. Paik, G. Viale, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

P. Fitzgibbons, P. Mangu, Robert B. Jenkins, 2022 .

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Anthony Rhodes, Lisa M McShane, Soonmyung Paik, 2006, Archives of pathology & laboratory medicine.

Fixation time does not affect expression of HER2/neu.

A. Gown, M. Hammond, M. Beasley, 2011, American journal of clinical pathology.

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

S. Schnitt, P. Fitzgibbons, Ruby Sg, 2000, Archives of pathology & laboratory medicine.

Breast cancer. Clinical practice guidelines in oncology.

B. Ljung, C. Hudis, W. Gradishar, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.

R. Gray, C. Osborne, N. Robert, 1995, Journal of the National Cancer Institute.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

C. Sturgeon, S. Paik, P. Fitzgibbons, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.